Are teicoplanin-non-susceptible Staphylococcus epidermidis strains increasing?

Researchers elucidated the incidence patterns of teicoplanin-non-susceptible Staphylococcus epidermidis (Teico-NS S. epidermidis) over six years.

Potent Rifampicin derivatives can clear MRSA infections at single low doses when concomitantly dosed with Vancomycin

Prevalence of strains with decreased susceptibility to teicoplanin

Limitations of presently available glycopeptides in the treatment of Gram‐positive infection - Ziglam - 2001 - Clinical Microbiology and Infection - Wiley Online Library

Inhibition Zone (mm) of Vancomycin and Teicoplanin Against

Antibiotics, Free Full-Text

Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: the AIDA open label, randomized, controlled Phase 4 trial - eClinicalMedicine

Are teicoplanin-non-susceptible Staphylococcus epidermidis strains increasing?

Frontiers Identification and Characterization of Staphylococcus aureus Strains with an Incomplete Hemolytic Phenotype

Frontiers Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis

Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis

Frontiers The Genome of Staphylococcus epidermidis O47

Methicillin-resistant Staphylococcus aureus

Frontiers Antimicrobial Resistance Profiles of Coagulase-Negative Staphylococci in Community-Based Healthy Individuals in Germany